{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:47:26Z","timestamp":1769845646291,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.molstruc.2021.130380","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:25:40Z","timestamp":1617751540000},"page":"130380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19"],"prefix":"10.1016","volume":"1237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-3554","authenticated-orcid":false,"given":"Shipra","family":"Bhati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joginder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molstruc.2021.130380_bib0001","unstructured":"World Health Organization- Coronavirus disease (COVID-19) pandemic, Situation Report-51. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200311-sitrep-51-covid-19.pdf (accessed 20 September 2020)"},{"key":"10.1016\/j.molstruc.2021.130380_bib0002","unstructured":"World Health Organization- Coronavirus disease (COVID-19) pandemic, WHO Coronavirus (COVID-19) Dashboard, https:\/\/covid19.who.int\/ (accessed 22 March 2021)"},{"key":"10.1016\/j.molstruc.2021.130380_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A Review of Coronavirus Disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J. Pediatr."},{"issue":"13","key":"10.1016\/j.molstruc.2021.130380_bib0004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.molstruc.2021.130380_bib0005","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130380_bib0006","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.molstruc.2021.130380_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173326","article-title":"Drug treatment of coronavirus disease 2019 (COVID-19) in China","volume":"883","author":"Jin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.molstruc.2021.130380_bib0008","doi-asserted-by":"crossref","first-page":"e05558","DOI":"10.1016\/j.heliyon.2020.e05558","article-title":"Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19","volume":"6","author":"Bhati","year":"2020","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.molstruc.2021.130380_bib0009","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6497","key":"10.1016\/j.molstruc.2021.130380_bib0010","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.molstruc.2021.130380_bib0011","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO. J."},{"key":"10.1016\/j.molstruc.2021.130380_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molstruc.2021.130380_bib0013","doi-asserted-by":"crossref","unstructured":"K. Anand, H.Yang, M.Bartlam, Z. Rao, R. Hilgenfeld, Coronavirus main proteinase: target for antiviral drug therapy, Coronaviruses with Special Emphasis on First Insights Concerning SARS (2005) 173\u2013199. 10.1007\/3-7643-7339-3_9","DOI":"10.1007\/3-7643-7339-3_9"},{"key":"10.1016\/j.molstruc.2021.130380_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.molstruc.2021.130380_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","author":"Boopathi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.130380_bib0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2016.07.009","article-title":"Antiviral activity of selected flavonoids against Chikungunya virus","volume":"133","author":"Lani","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.molstruc.2021.130380_bib0017","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00705-017-3417-y","article-title":"Flavonoids: promising natural compounds against viral infections","volume":"162","author":"Zakaryan","year":"2017","journal-title":"Arch. Virol."},{"issue":"9","key":"10.1016\/j.molstruc.2021.130380_bib0018","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/nu12092534","article-title":"Antiviral Properties of Flavonoids and Delivery Strategies","volume":"12","author":"Ninfali","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.molstruc.2021.130380_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109211","article-title":"Roles of flavonoids against coronavirus infection","volume":"328","author":"Russo","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130380_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-3542(89)90073-9","article-title":"Inhibition of reverse transcriptases by flavonoids","volume":"12","author":"Spedding","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1016\/j.molstruc.2021.130380_bib0021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/BF01941188","article-title":"Inhibitory effect of flavonoids on DNA-dependent DNA and RNA polymerases","volume":"44","author":"Shinozuka","year":"1988","journal-title":"Experientia"},{"issue":"2","key":"10.1016\/j.molstruc.2021.130380_bib0022","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","article-title":"Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity","volume":"19","author":"Bachmetov","year":"2012","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130380_bib0023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/v8010006","article-title":"Quercetin as an Antiviral Agent Inhibits Influenza a Virus (IAV) Entry","volume":"8","author":"Wu","year":"2015","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.molstruc.2021.130380_bib0024","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10529-011-0845-8","article-title":"Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris","volume":"34","author":"Nguyen","year":"2012","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.molstruc.2021.130380_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/14756366.2016.1265519","article-title":"Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors","volume":"32","author":"Park","year":"2017","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.130380_bib0026","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and Vitamin C: an Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.molstruc.2021.130380_bib0027","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/acs.jmedchem.5b01013","article-title":"Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease","volume":"58","author":"Zhai","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.130380_bib0028","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10989-018-9734-5","article-title":"In Silico Identification of Piperazine Linked Thiohydantoin Derivatives as Novel Androgen Antagonist in Prostate Cancer Treatment","volume":"25","author":"Bhati","year":"2018","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130380_bib0029","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5958\/0974-360X.2020.00150.X","article-title":"Computational screening of Thiohydantoin Derivatives for antitumor activity","volume":"13","author":"Ray","year":"2020","journal-title":"Research J. Pharm. Tech"},{"key":"10.1016\/j.molstruc.2021.130380_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings","volume":"64","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130380_bib0031","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.molstruc.2021.130380_bib0032","first-page":"123","article-title":"Computational Prediction of Synthetic Accessibility of Organic Molecules with Ambit-Synthetic Accessibility Tool","volume":"14","author":"Kochev","year":"2018","journal-title":"Org. Chem. Ind. J."},{"key":"10.1016\/j.molstruc.2021.130380_bib0033","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.molstruc.2021.130380_bib0034","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molstruc.2021.130380_bib0035","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple Ligand-Protein Interaction Diagrams for Drug Discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.molstruc.2021.130380_bib0036","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/ci200317s","article-title":"Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds","volume":"51","author":"Cheng","year":"2011","journal-title":"J. Chem. Inf. Model"}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021005135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021005135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:37:47Z","timestamp":1758325067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286021005135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"alternative-id":["S0022286021005135"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.130380","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.130380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130380"}}